<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in GlioblastomaMonika E. Hegi, Roger Stupp|New England Journal of Medicine|2005Cited by 7.2k
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With GlioblastomaRoger Stupp, Zvi Ram|JAMA|2017Cited by 2.5k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical TrialMark R. Gilbert, Minesh P. Mehta, Brigitta G. Baumert et al.|Journal of Clinical Oncology|2013Cited by 1.1k
Correlation of O<sup>6</sup>-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT ActivityMonika E. Hegi, Mark R. Gilbert, Lili Liu et al.|Journal of Clinical Oncology|2008Cited by 805
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upRoger Stupp, George Pentheroudakis|Annals of Oncology|2014Cited by 760